Insider of SER (SER) plans $279k sale of 91,000 shares

Rhea-AI Filing Summary

Randall Moreadith filed a Form 144 notice to sell 91,000 shares of common stock of SER through Stifel Nicolaus & Company on or about 01/20/2026 on the NYSE. The filing lists an aggregate market value of $279,370.00 for these planned sales and notes that 10,664,064 shares of this class were outstanding.

The 91,000 shares to be sold were acquired on 05/06/2021 via an option exercise from the issuer, with the transaction to be paid in cash. The notice also details multiple prior sales of SER common stock by Moreadith over the past three months, showing various sale dates, share amounts, and gross proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	91000	279370.00	10664064	01/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/06/2021	Option Exercise	Issuer			91000	01/20/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	01/14/2026	1084	2713.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	01/13/2026	5416	13540.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	01/08/2026	13000	34840.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	12/23/2025	4100	106600.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	12/22/2025	5673	15147.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	12/16/2025	3227	9562.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	12/12/2025	1700	5541.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	12/11/2025	3555	11520.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	12/10/2025	645	2161.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	12/09/2025	600	1988.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	12/02/2025	1500	5858.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	12/03/2025	5000	17623.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	11/25/2025	5965	23264.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	11/24/2025	535	2105.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	11/18/2025	6500	24402.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	11/10/2025	6500	26638.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	11/05/2025	3398	14395.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	11/04/2025	3102	13634.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	10/27/2025	949	4921.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	10/20/2025	6500	32287.00
Randall Moreadith 601 Genome Way Suite 2001 Huntsville AL 35806	Common Stock	10/28/2025	5551	27541.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the SER Form 144 filing disclose?

The Form 144 discloses that Randall Moreadith plans to sell 91,000 shares of SER common stock through Stifel Nicolaus & Company, with an aggregate market value of $279,370.00, on or about 01/20/2026 on the NYSE.

How many SER shares are planned to be sold under this Form 144 and at what value?

The notice covers a proposed sale of 91,000 shares of SER common stock with an aggregate market value of $279,370.00 as disclosed in the filing.

How many SER shares were outstanding according to this Form 144?

The filing states that 10,664,064 shares of the relevant class of SER common stock were outstanding at the time referenced in the document.

How and when did the insider acquire the SER shares being sold?

The 91,000 shares to be sold were acquired on 05/06/2021 via an option exercise from the issuer, with the filing indicating that the sale will be for cash on 01/20/2026.

Which broker is handling the proposed SER share sale in this Form 144?

The proposed sale of SER common stock is listed as being handled by Stifel Nicolaus & Company Inc., located at 501 N Broadway, St. Louis, MO 63102.

What prior SER stock sales by Randall Moreadith are reported in the last 3 months?

The filing lists multiple prior sales of SER common stock by Randall Moreadith between 10/20/2025 and 01/14/2026, each showing the sale date, the number of shares sold, and the gross proceeds for each transaction.

What representation does the insider make in signing the SER Form 144?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as stated in the form’s certification language.